HyperfineHYPR -12.76%77 Gross Margin % is 50.70% as of Mar. 2026, which is 80% above its 10-year median of 28.22. GuruFocus rates HYPR with a GF Score™ of 77/100 and a GF Value™ of $1.31 (Modestly Overvalued). The stock has 6 warning signs investors should review. Among 805 Medical Devices & Instruments companies, Hyperfine ranks worse than 51.68% on this metric.
Gross Margin % is calculated as gross profit divided by its revenue. Hyperfine's Gross Profit for the
three
months ended in Mar. 2026 was $1.98 Mil. Hyperfine's Revenue for the
three
months ended in Mar. 2026 was $3.90 Mil. Therefore, Hyperfine's Gross Margin % for the quarter that ended in Mar. 2026 was 50.70%.
The historical rank and industry rank for Hyperfine's Gross Margin % or its related term are showing as below:
HYPR'
s Gross Margin % Range Over the Past 10 Years
Min: -162.24 Med: 28.22 Max: 51.2
Current: 51.2
During the past 7 years, the highestGross Margin % of Hyperfine was 51.20%. The lowest was -162.24%. And the median was 28.22%.
HYPR's Gross Margin % is ranked worse than 51.68% of 805
companies
in the Medical Devices & Instruments industry
Industry Median: 52.07
vs HYPR: 51.20
Hyperfine had a gross margin of 50.70% for the quarter that ended in Mar. 2026 => Durable competitive advantage
The 5-Year average Growth Rate of Gross Margin for Hyperfine was 0.00% per year.
Hyperfine (NAS:HYPR) Gross Margin % Explanation
Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.
Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %
1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key
Hyperfine had a gross margin of 50.70% for the quarter that ended in Mar. 2026 => Durable competitive advantage
Be Aware
If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.
Hyperfine Gross Margin % Related Terms
Hyperfine Gross Margin % Historical Data
* Premium members only.
The historical data trend for Hyperfine's Gross Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
HYPR vs OWLT, CVRX, QTRX: Gross Margin % Comparison
For the Medical Devices subindustry, Hyperfine's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Hyperfine Gross Margin % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Hyperfine's Gross Margin % distribution charts can be found below:
* The bar in red indicates where Hyperfine's Gross Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.
Hyperfine (HYPR) has a Gross Margin % of 50.70% as of Mar. 2026. Gross margin is the ratio of total gross profit to net sales. View historical data on Hyperfine and its competitors. This is 80% above median its historical median of 28.22. According to the industry distribution chart, Hyperfine ranks #416 out of 805 companies in the Medical Devices & Instruments industry, placing it in the top 51.7%.
Is Hyperfine's Gross Margin % too high?
Hyperfine's current Gross Margin % of 50.70% is 80% above median its 10-year median of 28.22. The Medical Devices & Instruments industry median Gross Margin % is 52.07. Hyperfine's value of 50.70% is 2.6% below this industry median. Based on the distribution chart, Hyperfine ranks #416 out of 805 companies in the Medical Devices & Instruments industry, which is below the industry midpoint. Overall, Hyperfine has a GF Score™ of 77/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Hyperfine's Gross Margin % compare to OWLT and CVRX?
According to the Medical Devices & Instruments industry distribution chart, Hyperfine ranks #416 out of 805 companies for Gross Margin %. This places Hyperfine in the lower half of its industry. The industry median Gross Margin % is 52.07. Hyperfine's value of 50.70% is 2.6% below this benchmark. While the company's 10-year median is 28.22 vs. the industry median of 52.07, Hyperfine has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Gross Margin % for a Medical Devices & Instruments company?
The median Gross Margin % among Medical Devices & Instruments companies is 52.07, based on 805 companies in the industry. Companies in the top quartile (top 25%) have a Gross Margin % significantly above this median, while those in the bottom quartile fall well below. However, Gross Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Hyperfine's current Gross Margin % of 50.70% is 2.6% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Gross Margin % mean?
A high Gross Margin % can signal that a stock is expensive relative to its fundamentals. Gross margin is the ratio of total gross profit to net sales. View historical data on Hyperfine and its competitors. For the Medical Devices & Instruments industry, the median Gross Margin % is 52.07 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Hyperfine's current Gross Margin % is 50.70%, which is 80% above median its own 10-year median of 28.22. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Hyperfine stock overvalued right now?
Based on GuruFocus' analysis, Hyperfine (HYPR) is currently considered Modestly Overvalued. The stock's GF Value™ is $1.31, compared to a current price of $1.47 — trading 12.2% above its estimated fair value. The current Gross Margin % is 50.70%, which is 80% above median its 10-year median of 28.22 and 2.6% below the Medical Devices & Instruments industry median of 52.07. Hyperfine's overall GF Score™ is 77/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Gross Margin % calculated?
Gross Margin % is calculated from a company's financial statements. For Hyperfine (HYPR), the current Gross Margin % is 50.70% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Hyperfine (HYPR) Overvalued in 2026?
Based on GuruFocus' analysis, Hyperfine stock appears to be overvalued.
The current stock price of $1.47 is trading 12.2% above its estimated GF Value™ of $1.31.
GuruFocus considers Hyperfine to be Modestly Overvalued.
Key valuation signals for HYPR:
Gross Margin %: 50.70% (80% above median its 10-year median of 28.22)
GF Value™: $1.31 vs. price of $1.47 (12.2% above fair value)
Industry Position: 2.6% below the Medical Devices & Instruments median (#416 of 805)
No single metric tells the full story. See the HYPR stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Hyperfine Inc is a medical device company that created Swoop. The Swoop Portable MR Imaging System produces high-quality images at a lower magnetic field strength than conventional MRI scanners. The company derives its revenue from sale of sales of MRI devices and service sales, which consist of sales from subscriptions of bundled devices, maintenance, and software. The company is in the health technology business with a mission to revolutionize patient care globally through accessible, affordable, clinically relevant artificial intelligence (AI)-powered portable ultra-low-field (ULF) magnetic resonance (MR) brain imaging. The Company operates in one business segment, which includes all activities related to production, supply, service, and commercialization of the Swoop system.
77GF Score
Get the complete analysis for HYPR
Gross Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
HYPR has been successfully added to your 
